Reduced CD160 Expression Contributes to Impaired NK Cell Function and Poor Clinical Outcomes in Patients With HCC
Cancer Research - United States
doi 10.1158/0008-5472.can-18-1049
Full Text
Open PDFAbstract
Available in full text
Date
September 19, 2018
Authors
Publisher
American Association for Cancer Research (AACR)